• Kelyniam Global will present at the Planet MicroCap Las Vegas 2026 conference on June 17, 2026 at 4:30 p.m. PST.
• Management plans to outline its shift toward regenerative neurosurgery, including the recent FDA-cleared Fusion implant launch.
• Kelyniam reported Q1 2026 revenue of $1.15 million, up 84% year over year, with operating income of $295,295.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kelyniam Global Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606010001PR_NEWS_USPR_____NY70791) on June 01, 2026, and is solely responsible for the information contained therein.